175 related articles for article (PubMed ID: 20179156)
1. Human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease.
Johnson R; Richter N; Jauch R; Gaughwin PM; Zuccato C; Cattaneo E; Stanton LW
Physiol Genomics; 2010 May; 41(3):269-74. PubMed ID: 20179156
[TBL] [Abstract][Full Text] [Related]
2. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs in Huntington's disease neurodegeneration.
Johnson R
Neurobiol Dis; 2012 May; 46(2):245-54. PubMed ID: 22202438
[TBL] [Abstract][Full Text] [Related]
4. In vivo delivery of DN:REST improves transcriptional changes of REST-regulated genes in HD mice.
Conforti P; Mas Monteys A; Zuccato C; Buckley NJ; Davidson B; Cattaneo E
Gene Ther; 2013 Jun; 20(6):678-85. PubMed ID: 23151521
[TBL] [Abstract][Full Text] [Related]
5. Plasmids containing NRSE/RE1 sites enhance neurite outgrowth of retinal ganglion cells via sequestration of REST independent of NRSE dsRNA expression.
Koch JC; Barski E; Lingor P; Bähr M; Michel U
FEBS J; 2011 Sep; 278(18):3472-83. PubMed ID: 21790997
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes.
Bruce AW; Donaldson IJ; Wood IC; Yerbury SA; Sadowski MI; Chapman M; Göttgens B; Buckley NJ
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10458-63. PubMed ID: 15240883
[TBL] [Abstract][Full Text] [Related]
7. Gene dysregulation in Huntington's disease: REST, microRNAs and beyond.
Johnson R; Buckley NJ
Neuromolecular Med; 2009; 11(3):183-99. PubMed ID: 19458943
[TBL] [Abstract][Full Text] [Related]
8. High throughput screening for inhibitors of REST in neural derivatives of human embryonic stem cells reveals a chemical compound that promotes expression of neuronal genes.
Charbord J; Poydenot P; Bonnefond C; Feyeux M; Casagrande F; Brinon B; Francelle L; Aurégan G; Guillermier M; Cailleret M; Viegas P; Nicoleau C; Martinat C; Brouillet E; Cattaneo E; Peschanski M; Lechuga M; Perrier AL
Stem Cells; 2013 Sep; 31(9):1816-28. PubMed ID: 23712629
[TBL] [Abstract][Full Text] [Related]
9. The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease.
Buckley NJ; Johnson R; Zuccato C; Bithell A; Cattaneo E
Neurobiol Dis; 2010 Jul; 39(1):28-39. PubMed ID: 20170730
[TBL] [Abstract][Full Text] [Related]
10. Regulation of neural macroRNAs by the transcriptional repressor REST.
Johnson R; Teh CH; Jia H; Vanisri RR; Pandey T; Lu ZH; Buckley NJ; Stanton LW; Lipovich L
RNA; 2009 Jan; 15(1):85-96. PubMed ID: 19050060
[TBL] [Abstract][Full Text] [Related]
11. SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease.
Leone S; Mutti C; Kazantsev A; Sturlese M; Moro S; Cattaneo E; Rigamonti D; Contini A
Bioorg Med Chem; 2008 May; 16(10):5695-703. PubMed ID: 18406155
[TBL] [Abstract][Full Text] [Related]
12. Regulation of non-coding RNA networks in the nervous system--what's the REST of the story?
Qureshi IA; Mehler MF
Neurosci Lett; 2009 Dec; 466(2):73-80. PubMed ID: 19679163
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy of non-neuronal genes in peripheral lymphocytes from patients with Huntington's disease.
Marullo M; Valenza M; Mariotti C; Di Donato S; Cattaneo E; Zuccato C
Brain Pathol; 2010 Jan; 20(1):96-105. PubMed ID: 19134002
[TBL] [Abstract][Full Text] [Related]
14. Repressor element-1 silencing transcription factor (REST) is present in human control and Huntington's disease neurones.
Schiffer D; Caldera V; Mellai M; Conforti P; Cattaneo E; Zuccato C
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):899-910. PubMed ID: 24634989
[TBL] [Abstract][Full Text] [Related]
15. The central role of noncoding RNA in the brain.
Guennewig B; Cooper AA
Int Rev Neurobiol; 2014; 116():153-94. PubMed ID: 25172475
[TBL] [Abstract][Full Text] [Related]
16. Identification of REST targets in the Xenopus tropicalis genome.
Saritas-Yildirim B; Childers CP; Elsik CG; Silva EM
BMC Genomics; 2015 May; 16(1):380. PubMed ID: 25971704
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms of neurodegeneration in Huntington's disease.
Lee J; Hwang YJ; Kim KY; Kowall NW; Ryu H
Neurotherapeutics; 2013 Oct; 10(4):664-76. PubMed ID: 24006238
[TBL] [Abstract][Full Text] [Related]
18. Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease.
Desplats PA; Kass KE; Gilmartin T; Stanwood GD; Woodward EL; Head SR; Sutcliffe JG; Thomas EA
J Neurochem; 2006 Feb; 96(3):743-57. PubMed ID: 16405510
[TBL] [Abstract][Full Text] [Related]
19. Noncoding RNA transcripts.
Szymański M; Barciszewska MZ; Zywicki M; Barciszewski J
J Appl Genet; 2003; 44(1):1-19. PubMed ID: 12590177
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation by multiple promoters of the gene encoding the neuron-restrictive silencer factor.
Koenigsberger C; Chicca JJ; Amoureux MC; Edelman GM; Jones FS
Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2291-6. PubMed ID: 10688910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
